These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 20564984

  • 1. [Vaginal combined contraception NuvaRing in the clinical practice in the Czech Republic].
    Fait T.
    Ceska Gynekol; 2009 Aug; 74(4):286-91. PubMed ID: 20564984
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. An open-label, multicentre trial to evaluate the vaginal bleeding pattern of the combined contraceptive vaginal ring NuvaRing.
    Bruni V, Pontello V, Luisi S, Petraglia F.
    Eur J Obstet Gynecol Reprod Biol; 2008 Jul; 139(1):65-71. PubMed ID: 18358586
    [Abstract] [Full Text] [Related]

  • 4. The combined contraceptive vaginal device (NuvaRing): a comprehensive review.
    Sarkar NN.
    Eur J Contracept Reprod Health Care; 2005 Jun; 10(2):73-8. PubMed ID: 16147810
    [Abstract] [Full Text] [Related]

  • 5. The combined contraceptive vaginal ring (NuvaRing): first experience in daily clinical practice in The Netherlands.
    Roumen FJ, op ten Berg MM, Hoomans EH.
    Eur J Contracept Reprod Health Care; 2006 Mar; 11(1):14-22. PubMed ID: 16546812
    [Abstract] [Full Text] [Related]

  • 6. Weight gain, body image and sexual function in young patients treated with contraceptive vaginal ring. A prospective pilot study.
    Morotti E, Casadio P, Guasina F, Battaglia B, Mattioli M, Battaglia C.
    Gynecol Endocrinol; 2017 Aug; 33(8):660-664. PubMed ID: 28412867
    [Abstract] [Full Text] [Related]

  • 7. Clinical experience with NuvaRing in daily practice in Switzerland: cycle control and acceptability among women of all reproductive ages.
    Merki-Feld GS, Hund M.
    Eur J Contracept Reprod Health Care; 2007 Sep; 12(3):240-7. PubMed ID: 17763262
    [Abstract] [Full Text] [Related]

  • 8. Cycle control, tolerability, efficacy and acceptability of the vaginal contraceptive ring, NuvaRing: results of clinical experience in Germany.
    Brucker C, Karck U, Merkle E.
    Eur J Contracept Reprod Health Care; 2008 Mar; 13(1):31-8. PubMed ID: 17853162
    [Abstract] [Full Text] [Related]

  • 9. The contraceptive vaginal ring.
    Edwardson J, Jamshidi R.
    Semin Reprod Med; 2010 Mar; 28(2):133-9. PubMed ID: 20352563
    [Abstract] [Full Text] [Related]

  • 10. Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone.
    Ahrendt HJ, Nisand I, Bastianelli C, Gómez MA, Gemzell-Danielsson K, Urdl W, Karskov B, Oeyen L, Bitzer J, Page G, Milsom I.
    Contraception; 2006 Dec; 74(6):451-7. PubMed ID: 17157101
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 microg ethinyl estradiol and 3 mg drospirenone.
    Milsom I, Lete I, Bjertnaes A, Rokstad K, Lindh I, Gruber CJ, Birkhäuser MH, Aubeny E, Knudsen T, Bastianelli C.
    Hum Reprod; 2006 Sep; 21(9):2304-11. PubMed ID: 16763008
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Desogestrel-only contraceptive pill versus sequential contraceptive vaginal ring in the treatment of rectovaginal endometriosis infiltrating the rectum: a prospective open-label comparative study.
    Leone Roberti Maggiore U, Remorgida V, Scala C, Tafi E, Venturini PL, Ferrero S.
    Acta Obstet Gynecol Scand; 2014 Mar; 93(3):239-47. PubMed ID: 24372517
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [NuvaRing-combined contraceptive vaginal ring: state of art in 2008. Expert Board of Polish Gynecological Society].
    Debski R, Kotarski J, Paszkowski T, Pawelczyk L, Skrzypulec V, Tomaszewski J, Expert Board of Polish Gynecological Society.
    Ginekol Pol; 2008 Oct; 79(10):715-23. PubMed ID: 19058529
    [Abstract] [Full Text] [Related]

  • 18. Safety and efficacy of the NuvaRing® Applicator in healthy females: a multicenter, open-label, randomized, 2-period crossover study.
    Feldman R, Frenkl TL, Yacik C, Wang Y, Fox MC.
    Contraception; 2016 Oct; 94(4):362-5. PubMed ID: 27207028
    [Abstract] [Full Text] [Related]

  • 19. Contraceptive Vaginal Rings: Do They Pose an Increased Risk of Venous Thromboembolism in Aesthetic Surgery?
    Paresi RJ, Myers RS, Matarasso A.
    Aesthet Surg J; 2015 Aug; 35(6):721-7. PubMed ID: 26048332
    [Abstract] [Full Text] [Related]

  • 20. The contraceptive vaginal ring, NuvaRing(®), a decade after its introduction.
    Roumen FJ, Mishell DR.
    Eur J Contracept Reprod Health Care; 2012 Dec; 17(6):415-27. PubMed ID: 23113828
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.